Attorney General Bondi Joins Multistate Antitrust Action Against Generic Drug Companies
TALLAHASSEE, Fla.-Attorney General Pam Bondi and 19 other state attorneys general today filed a federal antitrust action against generic drug-maker Heritage Pharmaceuticals, Inc., Auribindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. The drug companies allegedly entered into numerous unlawful conspiracies to unreasonably restrain trade, artificially inflate and manipulate prices and reduce competition in the United States for two drugs. These drugs are doxycycline hyclate delayed release, an antibiotic, and glyburide, an oral diabetes medication.
- Date:December 16, 2016
- Agency:Florida Attorney General
- State Enforcement Agencies